Lenskart Solutions Initiating Coverage
Lenskart Solutions Initiating Coverage
SELL
INITIATING COVERAGE LKART IN EQUITY November 07, 2025
We expect Lenskart to deliver ~20% revenue CAGR over FY25–28 led by Recommendation
India expansion and rising global scale. GM gains and operating Mcap (bn): ₹697
leverage should drive ~630bps Pre-IND AS 116 EBITDAM expansion 6M ADV (mn): NA
(450bps vs proforma). However, as eyewear is a made-to-order category,
CMP: ₹402
scaling requires capacity investments (~65% utilization vs ~80% for other
TP (12 Mths): ₹337
categories), which along with goodwill keep the balance sheet heavy.
With capex of ~₹20bn over FY25–28E, FCF will turn positive only in FY28E. Upside/Downside (%): 16%
While its higher growth profile justifies premium vs retail universe, the
implied ~55× FY28E Pre-IND AS EV/EBITDA for India, 20-30% above Trent Flags
& Nykaa BPC, is unwarranted given lower RoCE/RoIC of ~9%/~13% vs Accounting: AMBER
peers’ 35-40% with similar revenue growth. CMP of ₹402 embeds 18% 2- Predictability: AMBER
decade revenue CAGR, implying ~60% of EssilorLuxottica’s (scale, multi-
Earnings Momentum: AMBER
banners, brands, R&D) current MS in retail. TP of ₹337 implies 45×/22×
EV/EBITDA for India/international. Risks: Higher India SSG and better
international profitability. Catalysts
Competitive position: STRONG Changes to this position: NEUTRAL ▪ Lower revenue CAGR of 21% over
FY25-27 vs 33% CAGR over FY23-25
Store expansion followed by rising global presence will drive growth ▪ Negative FCF of ₹7.3bn over FY25-
We see a store potential of ~5K stores for Lenskart in India. Ability to gain share 27 vs positive FCF of ₹2.2bn in FY25
from unorganized will drive productivity improvement. So we build in 17% store
count CAGR, which along with 4% CAGR in footfall-led productivity, will drive 20%
CAGR in India over FY25-28. We expect 18% CAGR in international business led
by Meller acquisition and Lenskart/Owndays store expansion.
Margin expansion driven by operating leverage on high cost base
While domestic store-level EBITDAM for matured stores is over 30%, international
operations and corporate (incl. employee costs) drag company-level EBITDAM to
~5.7%. Operating leverage (led by employee cost) and improving store vintage
globally will drive margin improvement of 450/465bps in India/international
operations over FY25-28E vs 7.5% proforma.
In-house mfg + acquisitions = asset-heavy B/S = lower RoCE vs peers
Unlike asset-light retailers outsourcing inventory, Lenskart’s vertically integrated
model and lower utilisation trigger (65% vs 75-80% for peers) constrain
improvement in capital efficiency. Inorganic expansion adds to this — goodwill
accounted for ~60%/70% of the Owndays/Stellio acquisition. So RoCE/RoIC will
remain structurally lower at 10%/15% till FY28E and can peak at 25-30%.
Premium valuations ignore lower RoCE, build stretched growth estimates Research Analysts
A 20% revenue CAGR over FY25-28E places Lenskart among the fastest-growing Videesha Sheth
retailers, comparable to Nykaa/Trent (23%/20%). Coupled with margin +91 22 66233264
expansion, it warrants a premium vs retail universe. But 55x India multiple (48x [Link]@[Link]
overall) FY28E Pre-IND AS 116 EV/EBITDA vs ~46×/~40× for Nykaa’s BPC/Trent Aryan Garodia
(11%/14% EBITDAM, FY28) with better RoCE suggests valuations are steep. +91 22 66233271
[Link]@[Link]
Key Financials Ronak Soni
Year to March (₹ mn) FY24 FY25 FY26E FY27E FY28E +91 22 6623 3009
Revenue 54,277 66,525 81,239 97,938 114,799 [Link]@[Link]
Gross margin 67.3% 67.9% 68.8% 69.1% 69.4% Sanket Gharat
EBITDA (Pre-IND AS 116) 1,960 3,821 7,540 10,489 13,824
+91 22 66233012
[Link]@[Link]
EBITDAM (Pre-IND AS 116) 3.6% 5.7% 9.3% 10.7% 12.0%
RoCE (Pre tax; Pre-IND AS 116) 0.0% 0.4% 5.1% 6.6% 8.7%
Source: Company, Ambit Capital research
Ambit Capital and/or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, investors should be aware that Ambit Capital
may have a conflict of interest that could affect the objectivity of this report. All Investors including US Investors should not consider this report as the only factor in making their investment decision.
Please refer to the Disclaimers and Disclosures at the end of this Report.
Lenskart Solutions
Narrative in charts
Exhibit 1: Based on per-store throughput of a mature Lenskart store and assuming an addressable TAM of 20%, Lenskart’s
current store potential would be 5-5.5K
Particulars Unit No. Comments
Revenue per matured store ₹ mn 25 Based on checks
ASP ₹ 2000 Based on checks
No. of pairs # 12500
Per household usage % 50% Assuming 2 people per household have glasses
Replacement factor % 50% Assuming 1 pair bought every 2 years
No. of households each store caters to # 12500
No. of households in India mn 330
% relevant households 20%
No. of relevant households mn 66
Store potential 5280
Source: Ambit Capital research; Red are assumptions
Exhibit 2: While unit economics of an efficient eyewear retailer are higher vs other fashion-centric categories due to the
requirement of lower inventory at store level…
Particulars (matured store) Jewellery Apparel Footwear Eyewear
Store size (sq ft) 4,000 8,000 1,500 900
Gross margin 18-20% 45-55% 55% 55%
Rent as % of rev 1.5% 12.0% 10.0% 8.0%
Employee as % of rev 0.8% 8.0% 10.0% 8.0%
Other overheads as % of rev 1.0% 15.0% 10.0% 8.0%
EBITDAM 15-17% 14-18% 20-25% 28-30%
EBITM 14-16% 10-15% 18-23% 25-28%
Inventory Turns 2.5-4x 3-6x 4-5x 8-10x
Total investment (₹ mn) 350-450 40-45 9-10 6-8
RoCE (pre tax) 30-40% 25-40% 50-60% 80-90%
Source: Ambit Capital research
Exhibit 3: …given Lenskart’s asset-heavy balance sheet due to in-house manufacturing and goodwill, company level RoCE is
lower vs other retailers
Lenskart Trent Nykaa Firstcry Zomato Swiggy
As a % of total assets
FY25 FY28 FY25 FY28 FY25 FY28 FY25 FY28 FY25 FY28 FY25 FY28
Tangible 19% 19% 24% 19% 22% 15% 12% 16% 3% 8% 8% 3%
Intangible 40% 29% 1% 1% 0% 0% 32% 26% 9% 8% 7% 7%
Working Capital* 7% 7% 14% 14% 44% 50% 24% 43% 2% 12% 5% 8%
Cash & Bank Balance 12% 24% 4% 21% 9% 12% 28% 11% 11% 10% 24% 6%
Others 22% 20% 57% 45% 25% 23% 4% 3% 76% 62% 56% 75%
EBITDAM (Pre IND-AS
6% 12% 13% 14% 4% 8% 0% 5% 3% 3% -18% 2%
116, %)
Asset T/o 1.0 1.0 2.1 2.1 3.4 4.7 1.3 1.9 0.6 3.2 1.1 2.9
RoCE (Pre-tax, Pre IND-
0% 9% 44% 41% 16% 40% -6% 4% -1% 6% -34% -10%
AS 116, %)
Source: Company, Ambit Capital research. *Working Capital = Inventories + Debtors – Creditors
Exhibit 4: Capacity expansion for integrated eyewear players are triggered at lower
utilization vs other manufacturing categories
40%
70%
30%
60%
20%
50%
10%
40% 0%
Eyewear FMCG/Paints Chemicals Pipes Electronics/ Cement
durables
Exhibit 5: Our near-term assumptions over FY25-28 build in 20%/35% revenue/EBITDA growth
CAGR over
CAGR over
FY25
Estimates FY25 FY25-28E/
FY25 FY26E FY27E FY28E (Proforma)- Comments
(₹mn unless specified) (Proforma) avg
28E/ avg
expansion
expansion
P&L
Revenue 66,525 68,030 81,239 97,938 114,798 20% 19% Revenue is expected to grow at
India 40,605 38,853 48,317 59,853 71,755 21% 23% a 20% CAGR from FY25 to
FY28, driven by 21%/18%
International 26,387 29,178 32,922 38,085 43,044 18% 14%
growth in India/International.
Stores 2,723 2,723 3,228 3,684 4,141 15% 15% India/International revenue
India 2,067 2,067 2,517 2,917 3,317 17% 17% growth of 21%/18% is driven by
International 656 656 711 767 824 8% 8% store expansion, which is
expected to grow at 17%/8%
CAGR coupled with 4%/9%
Gross profit 45,181 46,857 55,911 67,709 79,723 21% 19% improvement in store
productivity.
GM % 68% 69% 69% 69% 69% 51bps 19bps
EBITDA Pre-IND-AS 116 3,821 5,123 7,540 10,489 13,824 54% 39% EBITDAM expansion of 211bps
India 4,095 4,095 6,059 8,224 10,792 38% 38% will be driven by GM expansion
International 631 1,028 1,482 2,266 3,033 69% 43% of 51bps coupled with operating
leverage. EBITDAM on Pre-IND
EBITDAM Pre-IND-AS 116 5.7% 7.5% 9% 11% 12% 210bps 150bps AS basis is expected to see
India 10.5% 10.5% 13% 14% 15% 150bps 150bps expansion of 210bps over FY25-
International 2.4% 3.5% 5% 6% 7% 155bps 117bps 28E.
PAT 3,018 3,812 3,480 5,303 7,583 36% 26%
Balance Sheet
Net debt (excl lease
-15,068 -2,767 -26,972 -28,937 -33,411 NA NA
liabilities)
Cash conversion days on
26 25 26 26 26 0% 1% Margin improvement, coupled
sales
ROE 5% 6% 5% 6% 8% 97bps 50bps with steady working capital but
₹20bn capex over FY25-28
RoCE (pre-tax) 2% 3% 4% 5% 7% 96bps 115bps would lead to restricted
RoCE (pre-tax, Pre-IND AS
0% 2% 5% 7% 9% 167bps 225bps expansion in RoCE.
116)
RoCE (pre-tax, Pre-IND-AS
1% 3% 7% 9% 11% 212bps 272bps
116, excl. GW)
Cash flow parameters
CFO 12,306 NA 11,352 15,139 19,212 16% NA Cash flow improvement would
CFO Pre-IND AS 116 6,373 NA 3,846 6,236 8,947 12% NA be led by profitability
FCF 8,142 NA 894 8,197 12,223 15% NA improvement. FCF to be
FCF Pre-IND AS 116 2,208 NA -6,612 -706 1,958 NA NA negative till FY27 due to capex.
Exhibit 6: Reverse DCF implies 18% revenue CAGR over FY25-45 and market share of 5%....
CAGR
Market share size FY20 FY25 FY28 FY35 FY45
FY25-28E FY28E-35E FY35E-45E FY25-45E
India market size (₹bn) 429 788 1,137 2,393 4,847 13% 10% 7% 11.0%
Lenskart India revenue 9 39 72 206 809 22.7% 16.3% 14.6% 16.4%
India market share 2.1% 4.9% 6.3% 8.6% 16.7%
Global market size (₹bn) 13,622 15,207 17,604 23,633 31,187 5% 4% 3% 4.0%
Lenskart total revenue 9 65 115 314 1,253 20.7% 15.5% 14.8% 15.9%
Lenskart's global market
0.1% 0.4% 0.7% 1.3% 4.0%
share
Lenskart total revenue as
9 65 122 388 1,785 22.8% 18.0% 16.0% 18.0%
per RDCF
Lenskart's global market
0.1% 0.4% 0.7% 1.6% 5.7%
share as per RDCF
Source: Company, Ambit Capital research; Note: Red are assumption
Exhibit 7: …which is ~60% of EssilorLuxottica, the global giant’s, D2C (retail) business,
which currently runs ~18K stores under +10 banners globally
Global companies Current implied market share of global peers
EssilorLuxottica SA 15.8%
of which retail business 9.3%
Fielmann Group AG 1.3%
National Vision Holdings Inc 1.0%
Warby Parker Inc 0.4%
JINS Holdings Inc 0.4%
Source: Company, Ambit Capital research; Note: Direct to Consumer of EssilorLuxottica represents the retail business
of the Group, i.e., the supply of the Group’s products and services directly to the end consumer either through the
network of physical stores operated by the Group (brick and mortar) or the online channel (e-commerce)
Exhibit 8: At 6x, current valuation suggests Lenskart’s consol. Exhibit 9: Current valuation suggests Lenskart’s domestic
business trades at 10/35% premium to Trent /Nykaa, i.e. at (consol.) business trades at 55x (48x) FY28 pre IND AS 116
on FY28 EV/sales… EV/EBITDA, i.e., a premium of 20%/30% vs Nykaa BPC/Trent
100% 100%
FY25-28E EBITDA (Pre IND
FY25-28E Revenue CAGR
90%
Zomato 69
80% 80%
Zomato 1 70% Lenskart
AS CAGR)
Exhibit 10: …despite having a similar revenue growth over FY25-28, margin profile and
lower RoCE as Trent and similar revenue growth profile and lower ROCE vs Nykaa
50% Trent 41
FY28 RoCE (Pre-tax, Pre IND
40% Nykaa 61
Nykaa BPC 46
30%
AS 116)
20% Titan 38
Lenskart 48
10% Lenskart India 55
Zomato 69
0%
30 40 50 60 70 80
Source: Company, Ambit Capital research. Note: size of the bubble represents FY25 EBITDA (Pre-IND-AS 116)
Source: Ambit Capital research; Note: There is some overlap in location between demand, supply and choices
Exhibit 12: Eyewear has higher utilitarian element vs other categories requiring higher
service and technical innovation/quality
Jewellery Apparel Footwear Eyewear
Market size (₹ tn) 5.8-6.2 6.8-7.2 1-1.2 0.6-0.8
Organised (%) 35-40% 35-40% 40-45% 20-25%
Assortment Assortment
Assortment Assortment
Service Service
Core success lever Freshness Service
Trust Quality/innovation
Pricing Quality
Brand storytelling Turnaround Time
Source: Ambit Capital research
Exhibit 13: Reported revenue grew multi-fold from ₹9bn in FY20 to ₹66bn in FY25 at a CAGR of 49% due to India operation
growing at 35% CAGR and Owndays acquisition
100 300 400 500 600 700 1,100 1,959 2,389 2,723
Started with its first store in Singapore in 2019 Acquired Dealskart in Dec'25, a master
80 franchisee operation of 1,606 stores 160%
70 140%
60 120%
Revenue in Rs bn
40%
50 100%
42%
40 80%
30 38% 60%
Acquired MLO KK in Aug'22, holding Co. of Owndays Inc.
20 61% 40%
10% 59%
10 63% 20%
90%
0 0%
FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25
Source: Company, Ambit Capital research. Note: Box represents total store counts; Stores count prior to FY23 are based on media articles
Exhibit 14: Lenskart India AUTC* growth over FY23-25 stood at 26% vs 26%/14%/5% for
Nykaa (BPC)/Firstcry (India)/Zomato (Food ordering)
AUTC
FY23 FY24 FY25 FY23-25 CARG (RHS)
70 39% 45%
60 32% 40%
27% 35%
50 26% 26% 30%
40 25%
30 14% 13% 20%
20 15%
5% 10%
10 5%
0 0%
Zomato (Food
Myntra
Lenskart (Consol)
Nykaa (BPC)
Lenskart (India)
Nykaa (Fashion)
(International)
(International)
Firstcry (India)
ordering)
Lenskart
Firstcry
Source: Company, Ambit Capital research. * Annual Unique Transacting Customer
4.0 3.4
50%
25% 2.0
0% 0.0
FY21 FY22 FY23 FY23 FY24 FY25 1QFY25 1QFY26
Source: Lenskart RHP, Ambit Capital research. Note: Repeat rate pertains to the Source: Lenskart RHP, Ambit Capital research
2-year order repeat rate from new customers
Exhibit 17: Overall pairs sold per customer increased at 3% Exhibit 18: …led by 3%/4% increase in the
CAGR over FY23-25 to 2.19 for Lenskart… India/International channel to 2.3/1.7
2.50 6%
1.75 5%
2.00 5%
1.70
4%
1.50
1.65
3% 4%
1.00 1.60
2%
0.50 1% 1.55
- 0% 1.50 3%
FY23 FY24 FY25 1QFY26 FY23 FY24 FY25 1QFY26
Source: Lenskart RHP, Ambit Capital research Source: Lenskart RHP, Ambit Capital research
6 Proforma 18%
25 40%
35% 16%
20 30% 5
14%
15 25%
4 12%
20%
10 15% 10%
3
5 10% 8%
5% 2 6%
0 0%
4%
Page
Nykaa
Metro Brands
Myntra
Firstcry
Lenskart (SA)
(Consol.)
Trent
1
Lenskart
2%
- 0%
FY19
FY20
FY21
FY22
FY23
FY24
FY25
FY24
FY25
Source: Company, Ambit Capital research. Source: Company, Ambit Capital research
Exhibit 21: The company has stayed true to its value proposition, with ASPs range-bound
0 0%
FY23 FY24 FY25 1QFY26
Exhibit 23: India store count increased by 21% CAGR over Exhibit 24: International store count saw 10% CAGR over
FY23-25, with network increasing to 2,137 stores in 1QFY26 FY23-25 with network increasing to 669 stores in 1QFY26
Source: Lenskart RHP, Ambit Capital research Source: Lenskart RHP, Ambit Capital research
Exhibit 25: Units booked grew at 29% CAGR over FY23-25 led Exhibit 26: International units booked grew at 38% CAGR
by 31%/25% growth in offline/online channels in India over FY23-25 led by 38%/25% offline/online channel growth
25 22.91mn
Eyewear Units Booked
4
20 17.65mn 24% 4.29mn
(in mn)
3 3.58mn
(in mn)
15 13.69mn 25%
26% 2 97%
10 2.26mn 97%
76% 6.72mn
75% 20% 1 97% 1.13mn
5 74%
80% 97%
0 0
FY23 FY24 FY25 1QFY26 FY23 FY24 FY25 1QFY26
Source: Lenskart RHP, Ambit Capital research Source: Lenskart RHP, Ambit Capital research
Exhibit 27: Owndays has been a sizable acquisition making up for 85%/35% of international/company’s FY25 topline
Stake Acquisition/Inve Valuation
Name
Nature of business as on stment amount Multiple vs Rationale for acquisition
(FY of acquisition)
(in %) (₹ mn) sales
Expand the company's network and
MLO K.K/Owndays MLO K.K. acquires, holds, and disposes of establish a strong presence in more
100% 29,279 2.5-3x
(FY23). securities and other assets. countries, especially in Asian
markets.
Dealskart Online Services buys, sells, and trades
Dealskart Online Expand the company's network using
in apparel, accessories, and eyewear online. It
Services Pvt. Ltd. 100% 20 NA Dealskart's manpower and retail
also develops technology and software to
(FY25) network.
facilitate the sale of these goods.
Accelerate retail expansion and
Le Petit Lunetier
Le Petit Lunetier Paris sells optical products and solidify the brand's presence in
Paris SAS 29% 163
eyewear online and through wholesale. Europe, and introduce the brand to
(FY24)
the company's customers.
TISIPL designs, develops, and maintains
Tango IT Solutions software. It also imports, exports, sells, and
Use visual AI to improve store and
India Pvt. Ltd. distributes software and solutions. Additionally, it 100% 142
product experience.
(FY24) manufactures, sells, exports, and imports
electrical and electronic components.
Baofeng Framekart Baofeng Framekart Technology produces and
Develop and enhance eyewear
Technology Limited sells spectacle lenses, frames, and accessories. It 51% 28
manufacturing.
(FY21) also imports and exports goods and technology.
Visionsure Services provides vision benefits, NA
including product design, distribution, customer Engage in a joint venture to meet the
Visionsure Services
service, and benefits management. It also builds 50% 5 demand for vision insurance and
Pvt. Ltd. (FY25)
networks of eyewear providers and attract new customers.
ophthalmologists.
Develop a customer platform for
QuantDuo
real-time market intelligence to find
Technologies Pvt. QuantDuo Technologies develops analytics
17% 150 new store locations. This will support
Ltd. solutions for industries with large data sets.
data-driven expansion and optimize
(FY23)
store decisions.
Dimension NXG Dimension NXG manufactures, distributes, and
Enhance digital marketing and online
Pvt. Ltd. sells augmented and mixed reality solutions and 5% 215
engagement.
(FY26) products.
Stellio is in the import and sale of fashion To introduce a new sub-brand within
Stellio Ventures S.L.
accessories, under the brand name Meller and its 84% 4,125 1.8x portfolio, focused on Gen Z and
(FY26)
main activities are the retail trade of articles. Millennial customers
Quantduo Technologies main object is to To develop a customer platform to
develop analytics solutions for industries that enable real-time micro market
Quantduo deal with a large amount of data and carry on all intelligence, helping identify high-
Technologies Pvt. or any business of marketing and distributing the 96% 109 1.6x potential new store locations. This
Ltd.(FY26) software solutions developed by the Company deep integration supports data-
and provide consulting services directly to driven expansion and optimizes
consumers or enterprises. decision-making across stores.
Source: Lenskart RHP, Ambit Capital research, Note: Lenskart has 96% stake in Owndays – 92% through MLO KK and 4% through Lenskart Solutions Pte. Ltd.
Exhibit 28: International revenue grew at 159% CAGR over Exhibit 29: GM expansion of 400bps over FY23-25 plus
FY22-25 to ₹26bn, increasing its contribution to 39% in FY25 operating leverage led to EBITDAM expansion of ~750bps
Revenue Revenue YoY Growth (in %, RHS) GM (%) EBITDA (in %, RHS)
75% 20%
30 70%
60% 74% 18%
25
50%
in Rs bn
20 73% 16%
40%
15
30% 72% 14%
10
20%
71% 12%
5 10%
0 0% 70% 10%
FY22 FY23 FY24 FY25 FY23 FY24 FY25
Source: Lenskart RHP, Ambit Capital research Source: Lenskart RHP, Ambit Capital research
Exhibit 30: Lenskart International ASP stood at ₹6,151, which is above India/China but
below Japan, the Middle East and the USA
Japan
China
Southeast Asia
United States
Middle East
Lenskart
FY25)
Exhibit 31: Lenskart, led by its accessible price points, focus on fashion and quick delivery due to in-house manufacturing, has
seen India revenue CAGR of ~40% over FY19-25; below peers combined makeup for ~60% of Lenskart India’s scale
FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY19 FY20 FY21 FY22 FY23 FY24 FY25
Company Name
Revenue (₹ bn) Revenue YoY Growth (%)
Lenskart (Consol) 4.7 9.0 9.1 15.0 37.9 54.3 66.5 62% 90% 1% 66% 152% 43% 23%
Lenskart (SA) 4.7 8.9 8.8 14.4 23.7 31.9 40.4 62% 88% -2% 63% 65% 34% 27%
Lenskart (India,
22.4 30.6 38.9 36% 27%
Proforma)
Titan Eyewear 5.1 5.4 3.8 5.2 6.9 7.2 8.0 23% 6% -31% 38% 33% 5% 10%
Titan Eyewear - UCP 8.2 8.7 6.0 8.3 11.0 11.6 12.7 23% 6% -31% 38% 33% 5% 10%
Eye Gear Optics India 1.8 1.8 1.4 2.0 2.7 2.9 22% 5% -26% 48% 33% 7%
Sunglass Hut 1.4 1.5 0.9 1.7 2.7 2.7 26% 12% -42% 89% 62% 2%
Specsmakers 0.5 0.8 0.5 0.7 1.0 0.9 48% 46% -31% 31% 41% -4%
Reliance Vision Express 1.2 1.1 0.6 0.8 0.9 0.8 19% -4% -43% 20% 12% -11%
Gangar 1.2 1.1 0.6 0.8 1.0 0.9 -1% -9% -46% 36% 22% -7%
Dayal Opticals 0.5 0.5 0.4 0.5 0.8 0.8 18% -10% -25% 54% 40% 10%
Lawrence and Mayo 0.7 0.5 0.4 0.6 0.8 0.7 1% -26% -9% 43% 17% -10%
Vision World -
0.5 0.5 0.3 0.5 0.6 0.6 13% 5% -28% 36% 23% 7%
Himalaya Opticals
Himalaya Opticals 0.3 0.3 0.2 0.3 0.3 0.4 8% 7% -25% 30% 27% 8%
ClearDekho Eyewear 0.0 0.0 0.0 0.1 0.1 0.1 0% -9% 64% 70% 6% 59%
Source: Company, Ambit Capital research. Note: for unlisted companies financials are from MCA fillings; Titan UCP assuming is ~50% higher vs reported as
implied in 2024 analyst meet
Exhibit 32: Barring Sunglass Hut at ₹31mn (branded sunglasses), Lenskart has the highest
revenue/store within the peer set of ₹20mn
Revenue/Store
35 31
30
25 20
20 17
14
15
10 7 7
5 4
5 1
-
Gangar
Titan Eyewear
Reliance Vision
Specsmakers
Cleardekho
Lenskart India
India (Ben
Express
Frankin)
Mayo
Source: Company, Ambit Capital research. Note: In case of unlisted players like Reliance Vision Express, Specsmaker,
Sunglass Hut, Gangar, Eyegear Optics India, we have assumed store count (from store locator) as at 10 th August’25 is
similar that of 31st March 2024; Titan is on UCP basis assuming is ~50% higher vs reported as implied in 2024 analyst
meet
Exhibit 34: …coupled with operating leverage led to EBITDAM expansion of ~1700bps over FY19-25
FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY19 FY20 FY21 FY22 FY23 FY24 FY25
Company Name
EBITDA (in ₹ bn) EBITDA YoY Growth (%)
Lenskart (Consol) -0.3 -0.3 -0.5 -1.1 2.6 6.7 9.8 NA NA NA NA NA 155% 45%
Lenskart (SA) -0.3 -0.3 -0.4 -0.2 1.0 3.0 4.5 NA NA NA NA NA 185% 53%
Lenskart (India,
1.6 4.2 6.6 160% 57%
Proforma)
Titan Eyewear 0.1 0.3 0.7 0.9 1.5 1.5 1.6 -8% 124% 120% 29% 60% 1%
Eye Gear Optics India 0.1 0.1 0.0 0.1 0.1 0.0 NA 85% -85% 395% 33% -90%
Sunglass Hut 0.1 0.0 0.0 0.2 0.3 0.3 21% -82% NA NA 0% 0%
Specsmakers -0.1 -0.1 -0.1 -0.1 -0.1 0.0 NA NA NA NA NA NA
Reliance Vision Express -0.1 0.1 0.0 0.1 0.1 0.0 NA NA -87% 530% 10% -49%
Gangar 0.1 0.1 0.0 0.1 0.1 0.0 133% -19% -34% 126% -11% NA
Dayal Opticals 0.0 0.1 0.0 0.0 0.1 0.1 0.1 5% -46% 57% 78% 7% -10%
Lawrence and Mayo 0.0 -0.1 0.0 0.0 0.0 0.0 NA NA NA NA NA NA
Vision World -
0.0 0.0 0.0 0.0 0.1 0.1 0.0 68% 15% -33% 174% 37% -79%
Himalaya Opticals
Himalaya Opticals 0.0 0.0 0.0 0.0 0.0 0.0 0.0 -29% -63% -107% -3962% 12% -49%
ClearDekho Eyewear 0.0 0.0 0.0 -0.1 -0.1 -0.1 0% NA NA NA NA NA
EBITDAM (in %) EBITDAM Expansion/Contraction (in bps)
Lenskart (Consol) -6% -4% -5% -8% 7% 12% 15% 3,859 248 -160 -244 1,459 544 226
Lenskart (SA) -6% -3% -5% -2% 4% 9% 11% 3,849 252 -137 280 612 493 192
Lenskart (India,
7% 13% 16% 310 109
Proforma)
Titan Eyewear 3% 6% 19% 18% 22% 21% 20% -98 317 1,318 -121 364 -77 -126
Eye Gear Optics India 3% 5% 1% 4% 4% 0% 400 227 -415 253 2 -330
Sunglass Hut 4% 1% -3% 14% 11% 9% -15 -310 -367 1,696 -284 -172
Specsmakers -27% -18% -17% -9% -5% 1% 380 855 81 813 398 659
Reliance Vision Express -5% 8% 2% 10% 10% 6% 424 1,360 -649 837 -17 -436
Gangar 7% 7% 8% 13% 10% 0% 419 -75 142 527 -353 -983
Dayal Opticals 10% 6% 12% 14% 11% 9% -121 -387 647 195 -333 -201
Lawrence and Mayo -3% -11% -5% -5% 1% -3% -18 -779 600 2 547 -411
Vision World -
6% 7% 6% 13% 14% 3% 205 62 -48 650 147 -1,162
Himalaya Opticals
Himalaya Opticals 6% 2% 0% 6% 5% 2% -297 -384 -224 613 -73 -276
ClearDekho Eyewear -27% -106% -78% -85% -86% -57% -7,884 2,825 -743 -95 2,909
Source: Company, Ambit Capital research. Note: for unlisted players, financials are taken from MCA fillings
Exhibit 37: Barring Sunglass Hut (different product profile), Lenskart’s productivity is the
highest in the industry
Revenue/Store
35 31
30
25 20
20 17
15
9 7 7
10 5 4
5 1
-
Reliance Vision
Cleardekho
Gangar
Titan Eyewear
Specsmakers
Lenskart India
Lawrence and
Sunglass Hut
Express
Mayo
India
Source: Company, Ambit Capital research; Note: Sunglass Hut would be on the higher side as it caters to branded
sunglasses which are at higher ASP
Exhibit 39: Lenskart, followed by Zudio, has the highest share of stores in the top 8 cities
at 36% followed by Bata (31%), ABLBL (29%) and Reliance Trends (16%)
100 5%
947 935 591 301 271
0 0%
ABLBL Lenskart Bata Reliance Trends Zudio
Source: Company, Ambit Capital research. Note: ABLBL includes entire portfolio
Exhibit 40: Chennai, followed by Bangalore and MMR, have the highest store presence of
Lenskart
200 8%
150 6%
100 4%
50 2%
0 0%
Chennai
MMR
Hyderabad
Bengaluru
New Delhi
Pune
Kolkata
Ahmedabad
Exhibit 41: Lenskart can increase store presence. Store growth lies in Tier 1 and below cities, with limited headroom in the
top 8 cities
Total Store in % No. of Current store Store density Total store Incremental
Lenskart
Count Contribution cities density potential potential stores
Top 8 Cities 935 41% 8 117 125 1,000 65
Tier I 609 27% 60 10 25 1,500 891
Tier II 358 16% 105 3 10 1,050 692
Tier III 385 17% 252 2 5 1,260 875
Total 2,287 100% 4,810 2523
Source: Store locator, Ambit Capital research; Note: Top 8: Hyderabad, Bengaluru, Pune, Mumbai, Ahmedabad, Chennai, New Delhi, Kolkata, Tier 1: Other state
capitals or cities with 1-5mn population, Tier 2: 0.3-1mn population, Tier 3: <0.3mn population.
Exhibit 42: Store productivity for India/International increased by ~6% YoY in FY25 to
₹20mn/₹42mn
50 7%
6%
40
5%
30 4%
20 39 42 3%
2%
10 19 19 20
1%
0 0%
FY23 FY24 FY25
GM (in %) GM (in %)
EBITDAM (in %, RHS) EBITDAM (in %, RHS)
80% 15% 70% 20%
EBITDAM (Pre IND AS, in %, RHS) EBITDAM (Pre IND AS, in %, RHS)
10% 15%
60%
10%
65%
5%
5%
40%
0% 0%
60%
20% -5%
-5%
-10%
0% -10% 55% -15%
FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY19 FY20 FY21 FY22 FY23 FY24 FY25
Source: Company, Ambit Capital research Source: Company, Ambit Capital research
Exhibit 46: Employee spends are higher due to international operations, in-house
manufacturing and tech team costs
Employee Expense Reconciliation (FY25) Revenue Employee as a % of sale
Lenskart (SA) 40,392 3,963 10%
Subsidiary:
Owndays Co., Ltd 12,136 3,157 26%
Dealskart Online 16,304 3,266 20%
Owndays Singapore Pte. Ltd. 6,708 1,477 22%
Lenskart Solutions Pte. Ltd. 1,898 1,081 57%
Owndays Hong Kong Limited 1,329 473 36%
Lenskart Optical Trading LLC 835 346 41%
Lenskart Arabia Ltd 338 243 72%
Owndays Downunder Pty Ltd 220 88 40%
Others 2,409
Lenskart (Proforma - Consol) 68,030 16,500 24%
Source: Company, Ambit Capital research
Exhibit 47: Domestic profitability is better due to high opex in international; however, Dealskart acquisitions bumps up FY25
EBITDAM by ~180bps (FY25)
Reported (₹ bn unless specified) FY23 FY24 FY25 FY23-25 CAGR Proforma FY25 Variances
Revenue 38 54 67 33% 68 2%
India 24 32 41 30% 41 0%
International 14 23 26 36% 27 4%
EBITDA (Pre-IND AS 116) (0) 2 4 5 34%
India 0 2 4 4 0%
International (1) (0) 1 1 28%
EBITDM (Pre-IND AS, in %) -1% 3.6% 5.7% 336 bps. p.a 7.5% 179bps
India 0.9% 7.6% 10.5% 483 bps p.a. 10.5% 0bps
International -5.9% -0.4% 2.4% 413 bps p.a. 3.5% 113bps
Source: Company, Ambit Capital research
….but Lenskart’s centralized in-house mfg and capacity expansion will keep
RoCE lower vs peers
As eyewear is a curated, made-to-order product, utilization levels are lower than in sectors
where products are shelved, where production is driven by trade demand. Since capacities
must accommodate peak orders, integrated eyewear retailers like Lenskart typically
initiate capacity expansion once utilization reaches around 65%. Capex of ~₹20bn over
FY25-28 for the Hyderabad plant and store expansion will keep FCF in negative terrain
till FY27E. Hence, pre-tax RoCE/RoIC should improve from flat to ~10%/~14% by FY28E.
Exhibit 49: Lenskart has an asset-heavy balance sheet due to in-house manufacturing and goodwill, thus company level RoCE
is lower vs other retailers
Lenskart Trent Nykaa Firstcry Zomato Swiggy
As a % of total assets
FY25 FY28 FY25 FY28 FY25 FY28 FY25 FY28 FY25 FY28 FY25 FY28
Tangible 19% 19% 24% 19% 22% 15% 12% 16% 3% 8% 8% 3%
Intangible 40% 29% 1% 1% 0% 0% 32% 26% 9% 8% 7% 7%
Working Capital* 7% 7% 14% 14% 44% 50% 24% 43% 2% 12% 5% 8%
Cash & Bank Balance 12% 24% 4% 21% 9% 12% 28% 11% 11% 10% 24% 6%
Others 22% 20% 57% 45% 25% 23% 4% 3% 76% 62% 56% 75%
EBITDAM (Pre IND-AS
6% 12% 13% 14% 4% 8% 0% 5% 3% 3% -18% 2%
116, %)
Asset T/o 1.0 1.0 2.1 2.1 3.4 4.7 1.3 1.9 0.6 3.2 1.1 2.9
RoCE (Pre-tax, Pre IND-
0% 9% 44% 41% 16% 40% -6% 4% -1% 6% -34% -10%
AS 116, %)
Source: Company, Ambit Capital research. *Working Capital = Inventories + Debtors – Creditors
Exhibit 50: Capacity expansion for integrated eyewear players like Lenskart, will be
triggered at lower utilization than other manufacturing categories
40%
70%
30%
60%
20%
50%
10%
40% 0%
Eyewear FMCG/Paints Chemicals Pipes Electronics/ Cement
durables
days improved from 109 to 26 days, supported by a reduction in debtor days (from 95 to
7), along with better inventory and creditor management.
Exhibit 53: Lenskart has multiple fundraises, cumulatively Exhibit 54: Post IPO ~53%/16% of shareholding to be held by
raising ₹64bn over FY09-25 private equity or venture capital firms/promoters respectively
15 60%
62%
10 ~Rs8bn raised over FY09-19 40% 53%
5
20%
0 19% 16%
0%
FY09
FY12
FY13
FY14
FY15
FY16
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Pre IPO Post IPO
Source: Lenskart RHP, Ambit Capital research Source: Lenskart RHP, Ambit Capital research
Exhibit 55: ~88% of the funds were sourced externally Exhibit 56: …which were utilized for funding acquisition,
through equity/preference … capex and CFO
Capex
Investment/A
38%
cquisition
59%
Proceeds
from issue
of shares,
88%
Source: Company, Ambit Capital research Source: Company, Ambit Capital research
Exhibit 57: Standalone/consolidated CFO was negative, but Exhibit 58: …driven by improved inventory turns and higher
turned positive in FY24… operating profitability
CFO (Pre IND AS, Pre tax, in Rs mn) CFO (Pre IND AS, Pre tax, in Rs mn)
EBITDA (Pre IND AS, in Rs mn) EBITDA (Pre IND AS, in Rs mn)
3,000 8,000
2,000 6,000
4,000
1,000
2,000
0
0
-1,000 -2,000
-2,000 -4,000
FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY19 FY20 FY21 FY22 FY23 FY24 FY25
Source: Company, Ambit Capital research Source: Company, Ambit Capital research
Exhibit 59: Standalone FCF remained negative, while Exhibit 60: …driven by improved inventory turns and higher
consolidated FCF turned positive in FY25… profitability
FCF (Pre IND AS) PAT FCF (Pre IND AS) PAT
3,000 4,000
2,000
2,000
1,000
-
-
(1,000) (2,000)
(2,000)
(4,000)
(3,000)
(6,000)
(4,000)
(5,000) (8,000)
FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY19 FY20 FY21 FY22 FY23 FY24 FY25
Source: Company, Ambit Capital research Source: Company, Ambit Capital research
Exhibit 61: Standalone RoCE/RoE expanded by ~640/160bps Exhibit 62: Consolidated RoCE/RoE expanded by
over FY20-25 to 1%/3% driven by profitability ~770/450bps over FY20-25 to 3%/5% driven by profitability
ROCE* (Pre tax, Pre IND AS, in %) ROE (in %) RoCE* (Pre-tax, Pre IND AS 116, in %) ROE (in %)
5% 10%
0% 5%
-5% 0%
-10% -5%
-15% -10%
-20% -15%
FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY19 FY20 FY21 FY22 FY23 FY24 FY25
Source: Company, Ambit Capital research. *Ex-Goodwill Source: Company, Ambit Capital research. *Ex-Goodwill
Scope to play across multiple spectrums Titan Trent DMart Metro Nykaa Firstcry Lenskart
Highest score
Depth 4 4 4 4 4 4 4 4
Exhibit 66: Lenskart has high GM but higher opex due to 100% B2C revenue model; EssilorLuxottica is a century-old brand +
retail business, which allows it to make higher margins, but RoCE is still depressed due to capex and goodwill-heavy B/S
EssilorLuxottica in Euro mn Lenskart (proforma) in ₹ mn Titan Eye + in ₹ mn
CY23 CY24 CY23 CY24 CY23 CY24
Stores 17,589 17,638 2,389 2,723 902 897
Revenue 25,395 26,508 53,234 65,240 7,240 7,960
Revenue YoY Growth (%) 4% 4% 45% 23% 5% 10%
Revenue (UCP)* 11,559 12,708
Revenue (UCP) YoY Growth (%) 5% 10%
Gross margin (%) 63% 64% 67% 69%
Employee spends as a % of sale 32% 31% 25% 25%
Advertisement and marketing as a % of sale 7% 6% 8% 8%
Other expenses as a % of sale 0% 2% 20% 19%
Operating margin (%) 24% 25% 14% 17% 21% 20%
EBITDAM (Pre-INDAS 116) 20% 21% 4% 7%
EBIT 3,176 3,447 70 2,589 850 850
EBIT as a % of sale 13% 13% 0% 4% 12% 11%
ROE (%) 5% 6% 0% 6%
RoCE (%) 6% 6% 0% 3% 33% 33%
RoCE excl G/w (%) 13% 14% 6% 11%
Source: Company, Ambit Capital research; Note: The above is on reported post IND AS/IFRS basis; *Titan uniform consumer price (UCP) assuming is ~50% higher
vs reported as implied in 2024 analyst meet; ** Luxottica India is primarily operating through brand/wholesale model
Exhibit 67: EssilorLuxottica generates equal revenue from its B2B and D2C model
in Euro mn % of sales
EssilorLuxottica revenue
CY22 CY23 CY24 CY22 CY23 CY24
North America 11,492 11,637 11,978 47% 46% 45%
of which Professional Solutions 5,243 5,337 5,454 21% 21% 21%
of which Direct to Consumer 6,249 6,300 6,524 26% 25% 25%
EMEA 8,749 9,184 9,759 36% 36% 37%
of which Professional Solutions 3,802 3,949 4,142 16% 16% 16%
of which Direct to Consumer 4,947 5,235 5,617 20% 21% 21%
Asia Pacific 2,842 3,036 3,247 12% 12% 12%
of which Professional Solutions 1,943 2,088 2,164 8% 8% 8%
of which Direct to Consumer 899 948 1,083 4% 4% 4%
Latin America 1,410 1,537 1,523 6% 6% 6%
of which Professional Solutions 781 825 787 3% 3% 3%
of which Direct to Consumer 629 712 736 3% 3% 3%
Total 24,493 25,394 26,507
Source: Company, Ambit Capital research; Note: Professional Solutions represents the wholesale business of the
company including 300,000 third-party eyecare professionals and Direct to Consumer represents the retail business
Exhibit 69: Long-term assumption builds in 16%/24% CAGR over FY25-45E in revenue/EBITDA (Pre IND AS), with Pre-IND AS
116 EBITDAM/RoCE (pre-tax) increasing to 23%/34% respectively
CAGR
Estimates (₹ mn unless specified) FY25 FY28E FY35E FY45E
FY25-28E FY28E-35E FY35E-45E FY25-45E
Revenue (₹mn) 66,525 114,798 313,926 1,253,221 20% 15% 15% 16%
India 40,605 71,755 206,390 808,530 21% 16% 15% 16%
International 26,387 43,044 107,536 444,692 18% 14% 15% 15%
GM % 24% 18% 15% 15% -200bps -40bps -4bps -46bps
EBITDA (Pre-IND-AS 116) 3,821 13,824 54,425 284,327 54% 22% 18% 24%
EBITDAM (Pre-IND-AS 116, %) 6% 12% 17% 23% 210bps 76bps 54bps 85bps
ROE 5% 8% 19% 32% 97bps 157bps 130bps 134bps
RoCE (Pre-tax, Pre-IND-AS 116) 0% 9% 18% 34% 278bps 139bps 153bps 167bps
RoCE (Pre-tax, Pre-IND-AS 116; excl. G/w) 1% 11% 20% 35% 354bps 132bps 144bps 171bps
FCF (Pre-IND-AS 116) 2,208 1,958 23,966 156,622 -4% 43% 21% 24%
Source: Company, Ambit Capital research
Exhibit 71: Reverse DCF implies 18% revenue CAGR over FY25-45 and market share of 5%....
CAGR
Market share size FY20 FY25 FY28 FY35 FY45
FY25-28E FY28E-35E FY35E-45E FY25-45E
India market size (₹bn) 429 788 1,137 2,393 4,847 429 788 1,137 2,393
Lenskart India revenue 9 39 72 206 809 9 39 72 206
India market share 2.1% 4.9% 6.3% 8.6% 16.7% 2.1% 4.9% 6.3% 8.6%
Global market size (₹bn) 13,622 15,207 17,604 23,633 31,187 13,622 15,207 17,604 23,633
Lenskart total revenue 9 65 115 314 1,253 9 65 115 314
Lenskart's global market share 0.1% 0.4% 0.7% 1.3% 4.0% 0.1% 0.4% 0.7% 1.3%
Lenskart total revenue as per RDCF 9 65 122 388 1,785 9 65 122 388
Lenskart's global market share as per RDCF 0.1% 0.4% 0.7% 1.6% 5.7% 0.1% 0.4% 0.7% 1.6%
Source: Company, Ambit Capital research; Note: Red are assumptions
Exhibit 72: …half of EssilorLuxottica’s, the global giant’s retail business, which runs 18K
stores under ~10 banners in the affordable premium segment
Global companies Current implied market share of global peers
EssilorLuxottica SA 15.8%
of which direct to consumer business 9.3%
Fielmann Group AG 1.3%
National Vision Holdings Inc 1.0%
Warby Parker Inc 0.4%
JINS Holdings Inc 0.4%
Source: Company, Ambit Capital research; Note: Direct to Consumer of EssilorLuxottica represents the retail business
of the Group, i.e., the supply of the Group’s products and services directly to the end consumer either through the
network of physical stores operated by the Group (brick and mortar) or the online channel (e-commerce)
Exhibit 73: Trent and Nykaa score better on RoCE due to a better margin profile and asset-
light model
FY25; ₹ mn unless specified; Apparel BPC Childcare Eyewear (Lenskart)
Pre-IND AS 116 (Trent) (Nykaa) (Firstcry) Proforma Reported
Own Brand Mix (in %) 100% 14% 55% 95% 95%
GM (%) 44% 44% 37% 69% 68%
Employee (%) 7% 9% 10% 25% 21%
Branding/marketing (%) 1% 13% 8% 8% 7%
Fulfilment (%) 3% 9% 9% 4% 3%
Rent Pre-IND AS 13% 2% 4% 10% 9%
Commission to franchisees (%) - - - 0% 11%
EBITDAM (Pre-IND AS) (%) 13% 4% 0% 7% 6%
Core business EBITDAM** 10% 2% 11% 11%
EBITM Pre-IND AS (%) 11% 3% -3% 1% 0%
Inventory turns (x) 8.2 6.1 2.6 6.0 6.2
Asset turn (x) 2.4 2.4 1.2 0.8/1.1* 0.8/1.1*
Pre-IND AS 116 RoCE 44% 16% -6% 1% 0%
Pre-IND AS 116 RoCE (ex goodwill) 44% 16% -7% 2% 1%
Source: Company, Ambit Capital research; Note: The above numbers are at the consolidated level; we have added
Trent for comparison with other offline retailers; *Asset turn (excl. Goodwill); **Core business includes India business
for Lenskart, B2C BPC for Nykaa and multi-channel India business for Firstcry
Exhibit 74: Current valuation suggests FY28 pre IND AS EV/EBITDAM multiple of 55x/30x/48x for Lenskart’s
India/international/consol. segments; India multiples are at a premium of 20-30% of Nykaa & Trent and international at
~50% premium of global peers which trade at 10-22x
Trent Lenskart Nykaa
Business segments
Fashion Domestic Global BPC Fashion
Mkt Size (₹tn) 7.0 0.8 1.5 1.5 0.7
Org mkt growth (₹tn) 12% 14% 4% 12% 15%
Company comps
Revenue growth profile (FY25-28) 20% 23% 17% 23% 20%
EBITDA pre IND AS 116 growth profile (FY25-28) 23% 35% 65% 23% 20%
Margin profile (FY28) 14% 15% 7% 11% 5%
RoCE profile (FY28) 40% 11% 3% 35-40% 10%
Pre IND AS116 EV/EBITDA (FY28) 41 55 25 48 NA
Source: Company, Ambit Capital research
Exhibit 75: Expect revenue CAGR of 16% for FY25-45E in Exhibit 76: …with EBIT CAGR in FY25-45E at 42%, one of the
Lenskart… highest among discretionary/new age peers, on low base
Titan
Swiggy
Nykaa
Swiggy
Nykaa
Zomato
Firstcry
Zomato
Firstcry
Trent
Trent
Lenskart
Lenskart
Source: Company, Ambit Capital research. 1FY25-40E Source: Company, Ambit Capital research 1FY27-40E 2FY29-40E 3FY28-40E
Exhibit 77: At 6x, current valuation suggests Lenskart’s Exhibit 78: Current valuation suggests Lenskart’s domestic
consol. business trades at 10/35% premium to Trent /Nykaa, (consol.) business trades at 55x (48x) FY28 pre IND AS 116
i.e. at on FY28 EV/sales… EV/EBITDA, i.e., a premium of 20%/30% vs Nykaa BPC/Trent
100% 100%
90%
Zomato 69
80% 80%
Zomato 1 70% Lenskart
AS CAGR)
60% Swiggy 1 60% 48
Nykaa 61
50% Titan 37
40% Nykaa 5 40%
Trent 6 Lenskart
30% Nykaa BPC India 55
20% 20% 46
Firstcry 2 Titan 4 Lenskart 6 10% Trent 41
0% 0%
0 2 4 6 30 40 50 60 70 80
Exhibit 79: …despite having a similar revenue growth over FY25-28, margin profile and
lower RoCE as Trent and similar revenue growth profile and lower ROCE vs Nykaa
50% Trent 41
FY28 RoCE (Pre-tax, Pre IND
40% Nykaa 61
Nykaa BPC 46
30%
AS 116)
20% Titan 38
Lenskart 48
10% Lenskart India 55
Zomato 69
0%
30 40 50 60 70 80
Source: Company, Ambit Capital research. Note: size of the bubble represents FY25 EBITDA (Pre-IND-AS 116)
Risks
▪ International business profitability: Currently, we are assuming international
business will expand Pre-IND AS 116 EBITDAM by 465bps to 7% by FY28, lower vs
India business’ EBITDAM of 15%. If the company is able to bring in more efficiencies
in the International business, margin expansion could be higher than expected.
▪ Incubation of newer banners: There would be upside risk to growth estimates if
the company launches/acquires new formats.
Exhibit 81: Lenskart trades at 10%/30% premium to Trent/Nykaa on FY28 EV/Sales; 48x FY28E EV/EBITDA (Pre-IND AS) vs 41x for Trent with similar revenue growth and FY28
EBITDAM of 12% vs 13% respectively; Lenskart’s international business seems to be trading at a 50% premium to global peers
Current EV/EBITDA
Mcap Mcap EV/Sales P/E FY25-28 growth RoE
BBG Code Company CMP TP (₹) Rating (Pre IND AS)
(₹ bn) ($mn)
FY26E FY27E FY28E FY26E FY27E FY28E FY26E FY27E FY28E Revenue EBITDA PAT FY26E FY27E FY28E
LKART IN EQUITY Lenskart Solutions Ltd 697 7,890 402 337 SELL 9 7 6 89 64 48 202 132 92 20% 35% 36% 5% 6% 8%
Jewellery
TTAN IN EQUITY Titan Co Ltd 3,386 38,164 3,814 4,091 BUY 6 5 4 54 46 38 77 61 51 16% 18% 26% 24% 26% 27%
KALYANKJ IN EQUITY Kalyan Jewellers India Ltd 540 6,083 523 NA NR 2 1 1 20 17 13 47 38 31 24% 26% 35% 21% 22% 22%
SENCO IN EQUITY Senco Gold Ltd 55 617 334 594 BUY 1 1 1 12 10 8 21 18 14 19% 22% 20% 12% 13% 14%
Apparel & Value Retail
DMART IN EQUITY Avenue Supermarts Ltd 2,722 30,680 4,182 3,693 SELL 4 3 3 54 45 38 87 72 61 17% 17% 15% 13% 14% 14%
TRENT IN EQUITY Trent Ltd 1,657 18,676 4,661 4,696 SELL 8 7 6 62 50 41 95 72 58 21% 24% 21% 26% 28% 28%
VMM IN Equity Vishal Mega Mart Ltd 670 7,555 143 130 SELL 5 5 4 54 46 39 84 70 58 17% 19% 22% 12% 13% 14%
PAG IN EQUITY Page Industries Ltd 448 5,046 40,135 36,662 SELL 9 8 7 39 35 31 60 53 46 10% 10% 10% 48% 45% 43%
Aditya Birla Lifestyle
ABLBL IN EQUITY 167 1,886 137 142 SELL 3 2 2 25 20 17 80 51 36 9% 12% 98% 15% 20% 23%
Brands Ltd
Aditya Birla Fashion and
ABFRL IN EQUITY 103 1,157 84 79 SELL 2 1 1 NA NA NA NA NA NA 13% 27% NA NA NA NA
Retail Ltd
MANYAVAR IN
Vedant Fashions Ltd 157 1,766 645 NA NR 11 10 9 20 18 138 40 35 31 9% 8% 7% 21% 21% 21%
EQUITY
VREL IN Equity V2 Retail Ltd 89 1,008 2,452 NA NR 3 2 NA 24 NA NA 64 35 NA NA NA NA 28% 34% NA
VMart IN Equity V-Mart Retail Ltd 66 745 832 NA NR 2 2 1 14 12 473 69 49 34 17% 23% 60% 11% 14% 15%
STYLEBAA IN Equity Baazar Style Retail Ltd 25 280 333 NA NR 2 2 1 NA NA NA 108 64 37 24% 28% 65% 6% 10% 13%
SHOP IN Equity Shoppers Stop Ltd 53 601 484 NA NR 2 2 1 14 13 NA 190 85 67 12% 8% 125% 4% 13% 14%
GOCOLORS IN
Go Fashion India Ltd 35 392 645 NA NR 4 3 3 13 11 NA 37 30 25 13% 13% 15% 13% 13% 14%
EQUITY
VMart IN Equity V-Mart Retail Ltd 59 667 739 NA NR 2 2 1 18 14 11 128 55 39 16% 23% 64% 6% 12% 15%
Footwear
METROBRA IN EQUITY Metro Brands Ltd 308 3,470 1,130 1,356 BUY 11 9 8 50 42 34 75 62 50 17% 18% 20% 23% 27% 31%
BATA IN EQUITY Bata India Ltd 137 1,545 1,066 1,004 SELL 4 4 3 30 27 23 57 51 42 6% 9% -1% 15% 16% 18%
RLXF IN EQUITY Relaxo Footwears Ltd 108 1,216 433 415 SELL 4 3 3 27 24 21 52 44 37 8% 14% 20% 10% 11% 12%
CAMPUS IN EQUITY Campus Activewear Ltd 84 950 276 253 SELL 5 4 4 36 30 25 63 49 40 11% 17% 20% 17% 19% 20%
New Age
NYKAA IN FSN E-Commerce
718 8,091 251 262 BUY 7 6 5 130 84 61 371 170 105 24% 45% 110% 14% 25% 30%
EQUITY Ventures Ltd
FIRSTCRY IN EQUITY Brainbees Solutions Ltd 182 2,053 349 395 SELL 2 2 2 NA NA 100 -971 58 29 16% 62% NA NA 0% 4%
HONASA IN EQUITY Honasa Consumer Ltd 91 1,030 281 397 BUY 4 3 3 67 49 36 58 42 30 15% 62% 52% 11% 13% 16%
Current EV/EBITDA
Mcap Mcap EV/Sales P/E FY25-28 growth RoE
BBG Code Company CMP TP (₹) Rating (at CMP)
(₹ bn) ($mn)
FY25 FY26E FY27E FY25 FY26E FY27E FY25 FY26E FY27E Revenue EBITDA PAT FY25 FY26E FY27E
QSR
JUBI IN EQUITY Jubilant Foodworks Ltd 392 4,414 593 588 SELL 6 5 5 46 37 31 138 88 68 16% 19% 44% 12% 16% 19%
DEVYANI IN NA NA NA
Devyani International Ltd 196 2,213 159 139 SELL 4 3 3 36 28 22 247 113 68 15% 123% NA
EQUITY
SAPPHIRE IN
Sapphire Foods India Ltd 92 1,032 285 353 BUY 3 3 2 36 25 19 560 105 69 13% 19% 100% 2% 7% 9%
EQUITY
Eyewear (Global Peers)
EL FP EQUITY EssilorLuxottica SA 14,933 168,330 32,242 NA NR 6 5 5 26 25 22 45 40 35 11% 13% 26% 7% 8% 9%
FIE GR EQUITY Fielmann Group AG 399 4,501 4,754 NA NR 2 2 2 10 9 9 19 17 15 11% 16% 24% 21% 21% 21%
3046 JP EQUITY JINS Holdings Inc 105 1,183 4,378 NA NR 2 2 1 10 9 9 20 18 16 9% 11% 10% 26% 24% 22%
National Vision Holdings
EYE US EQUITY 180 2,027 2,271 NA NR 1 1 1 37 31 26 37 31 26 8% 9% NA 7% 7% 8%
Inc
WRBY US EQUITY Warby Parker Inc 213 2,396 1,743 NA NR 3 2 2 27 21 16 74 44 36 17% 52% NA 11% 12% 14%
Source: Bloomberg, Ambit Capital research. Note: Updated as of 5 Nov 2025
th
Media articles suggest franchisees have alleged unfair competition (new company stores
nearby), opaque accounting, manipulated settlements, and forced renovations, with FI₹
filed in Karnataka and Indore citing financial fraud. Based on other media articles,
franchisees have complained to SEBI, alleging Lenskart has under-reported the scale of
an FIR involving 13 stores, accusing it of financial manipulation and disclosure lapses in
its RHP. We believe that the financial materiality is limited – 13 outlets versus a ~2.1K
store network, but the concern is more about governance and accountability, and SEBI is
likely to seek clarifications. Store-level checks show reported numbers corroborate
footfalls and sales. Even FirstCry followed a similar path, initially scaling through
franchisees to keep the balance sheet light before COCO stores became dominant
Annexure
The global eyewear market is valued at ~₹15tn (~USD177bn) in FY25, is
primarily driven by prescription eyeglasses (~70%), followed by contact lenses
and sunglasses. Top global markets by value include the United States (27-31%),
Europe (22-31%), China (12-16%), India (5%, and Japan (4%). India's eyewear
market, at ~₹788 billion (~USD9.2bn) in FY25, is projected to reach ~₹1.5tn
(~USD17.2bn) by FY 2030, growing at a ~13% CAGR. Prescription eyeglasses
dominate the Indian market, accounting for ~73% of its value. Growth is spurred
by rising refractive errors, increasing disposable incomes, expanding retail
access, and a shift towards organized players. In India, FY25 saw 274mn units
sold (11.2% CAGR over FY20-25) at an average selling price (ASP) of ~₹2,370
(~US$28) (2.6% CAGR over FY20-25).
Exhibit 92: Europe, together with the US, accounts for 60% of the global market, while
China, India & Japan together account for 20%
Europe
37%
India…
China…
US
23%
Exhibit 93: India and Southeast Asia show higher growth potential in organised prescription eyeglasses (20% and 14–17%
CAGR), while Japan and the Middle East are more mature markets with lower growth (3% and 11%). Overall, prescription
eyeglasses remain the largest eyewear segment across regions, contributing >50%
Time Southeast Middle
Parameters Units India Japan
Period Asia East
Population A mn FY25 1,454 614 124 45
FY25 53% 65% 68% 40%
Prevalence of Refractive Errors B %
FY30E 62% 70% 71% 42%
FY25 771 399 84 18
Population with Refractive Errors C= A*B mn
FY30E 901 430 88 19
Prescription Eyeglasses Market
FY25 35% 40% 69% 60%
Penetration of Prescription Eyeglasses D %
FY30E 41% 44% 64% 64%
FY25 270 160 58 11
Population with Prescription Eyeglasses E = C*D mn
FY30E 370 189 56 12
Annual Spend per user on Prescription Eyeglasses F in ₹ FY25 2,089 2,729 5,768 10,309
Prescription Eyeglasses Market Size G = E*F in ₹ bn FY25 563 436 336 111
% of Eyewear FY25 23% 28-30% 53% 55-60%
Organised Share of Prescription Eyeglasses
Market by value FY30E 30% 35-40% 59% 67-72%
Prescription Eyeglasses Organised Market Growth Rate % FY25-30E 20% 14-17% 3% 11%
% of Eyewear
Share of Prescription Eyeglasses FY25 73% 69% 48% 69%
Market by value
Other Categories and Overall Eyewear Market
Contact Lenses Market Size H in ₹ bn FY25 41 49 290 22
Sunglasses Market Size I in ₹ bn FY25 174 149 68 28
Total Eyewear Market Size in ₹ bn FY25 788 637 690 162
Eyewear Market Growth Rate % FY25-30E 13% 7% 3% 7%
Source: Lenskart RHP, Ambit Capital research. Note: Red denotes assumption
Exhibit 94: Global/India market grew by 3%/13% CAGR over Exhibit 95: …3%/13% CAGR over the same period in the
FY25-FY30E to ₹18.7tn/₹1.5tn led by… prescription eyeglasses to ₹13tn/₹1tn by FY30E
in Rs bn
15% 5%
8,000 800
70% 6% 22%
69% 70% 73%
4,000 400 25% 73%
69%
0 0
FY20 FY25 FY30E FY20 FY25 FY30E
Source: Lenskart RHP, Ambit Capital research. Box represents total market size Source: Company, Ambit Capital research. Box represents total market size (in
(in ₹ tn) ₹ tn)
Exhibit 96: Total market volume is expected to increase at 9% Exhibit 97: ASP of prescription
CAGR over FY25-30E led by 10% increase in Prescription eyeglasses/sunglasses/contact lenses is expected to increase
eyeglasses/sunglasses at 3%/4%/2% CAGR over FY25-30E to ₹2,797/₹1,691/₹246
Prescription Eyeglasses Sunglasses Contact Lenses FY20 (in Rs) FY25 (in Rs) FY30 (in Rs)
2040
700 30% 2000 1691
600
1500
500 23% 1165
34%
400 1000
300 35% 22%
500 194 246
200 26% 46%
100 44% 0
39%
0 Prescription Sunglasses Contact Lenses
FY20 FY25 FY30E Eyeglasses
Source: Lenskart RHP, Ambit Capital research. Box represents total market Source: Lenskart RHP, Ambit Capital research *CAGR over FY20-30E
volume (in mn units)
3-4x
100%
80%
60%
60%
100% 40% 7-15% 25-33%
40%
20%
0%
Retail Price
Retail Markup
ACP
Distributor Markup
Trade Price
Exhibit 99: Supply chain mark-up for single vision lenses Exhibit 100: Supply chain mark-up for progressive lenses
2.7-3x 3-4x
100% 100%
80% 80%
56%
60% 60%
100% 44% 7-11% 100%
40% 56% 33-37% 40%
11-19% 25-33%
20% 20% 44%
0% 0%
Retail Price
Retail Markup
ACP
Retail Price
Retail Markup
ACP
Distributor
Trade Price
Distributor
Trade Price
Markup
Markup
Source: Lenskart RHP, Ambit Capital research Source: Lenskart RHP, Ambit Capital research
We value Lenskart using DCF value methodology, taking into ▪ Higher store productivity in domestic business
consideration free cash flow till FY45E using WACC 13% and
terminal growth rate of 7% to arrive at a TP of ₹337. ▪ Better efficiencies in international business
Financials - CONSOLIDATED
Income statement
Year to March (₹ mn) FY24 FY25 FY26E FY27E FY28E
Revenue 54,277 66,525 81,239 97,938 114,798
-growth (Rev) 43.3% 22.6% 22.1% 20.6% 17.2%
Cost of goods sold 17,761 21,344 25,328 30,229 35,075
Gross profit 36,516 45,181 55,911 67,709 79,723
Employee expenses 10,865 13,788 19,409 23,047 26,610
Advertising/marketing expenses 3,521 4,484 6,420 7,585 8,713
Other expenses 18,917 21,639 21,455 25,270 29,024
EBITDA 6,733 9,755 15,047 19,392 24,089
-growth (EBITDA) 155% 44.9% 54.3% 28.9% 24.2%
Depreciation 6,722 7,966 10,689 13,933 15,931
EBIT 11.1 1,789 4,358 5,459 8,158
Other income 1,822 3,568 1,732 2,846 3,029
EBIT (including other income) 1,833 5,357 6,091 8,304 11,187
Finance costs 1,230 1,459 1,595 1,454 1,393
Share of profit/loss of associates and JVs (12.5) (44) - - -
Profit before tax 590 3,854 4,495 6,850 9,794
Profit before tax (adjusted) 590 3,854 4,495 6,850 9,794
Tax 692 880 1,015 1,547 2,211
PAT (101) 2,973 3,480 5,303 7,583
Profit after tax (adjusted) (101) 2,973 3,480 5,303 7,583
Consolidated profit after tax (101) 2,973 3,480 5,303 7,583
EPS (basic) (₹) (0.1) 1.8 2.0 3.0 4.3
EPS (diluted) (0.1) 1.8 2.0 3.0 4.3
Source: Ambit Capital research, Company
Balance sheet
Year to March (₹ mn) FY24 FY25 FY26E FY27E FY28E
Property, plant and equipment 46,865 41,228 48,602 51,090 53,149
Capital work in progress 708 1,069 5,069 5,069 5,069
Right of use assets 8,144 21,085 19,315 17,778 17,043
Total fixed assets 55,717 63,382 72,986 73,937 75,261
Non-current investments 416 500 500 500 500
Deferred tax assets (net) (1,066) (700) (700) (700) (700)
Other non-current assets 4,359 3,713 4,449 5,282 6,129
Total non-current assets 59,426 66,895 77,235 79,019 81,190
Inventories 6,881 10,814 13,206 15,921 18,662
Current investments 9,616 9,878 1,000 1,000 1,000
Trade receviables 3,414 1,259 1,537 1,853 2,172
Cash and cash equivalents 8,052 8,649 29,432 31,397 35,871
Other current assets 6,411 5,700 6,961 8,391 9,836
Total current assets 34,373 36,300 52,136 58,562 67,541
Total assets 93,799 103,195 129,371 137,581 148,731
Share capital 1,824 3,214 3,321 3,321 3,321
Other equity 54,669 57,773 82,627 87,902 95,446
Minority interest 1,067 1,074 1,094 1,122 1,160
Total equity 57,559 62,062 87,042 92,345 99,927
Long-term borrowings 2,681 2,115 2,115 2,115 2,115
Long-term provisions 659 920 1,124 1,355 1,588
Lease liabilities 16,787 22,268 20,056 19,096 18,759
Other non-current liabilities 4,893 2,401 2,932 3,534 4,143
Total non-current liabilities 25,020 27,705 26,227 26,101 26,605
Short-term borrowings 2,290 1,344 1,344 1,344 1,344
Trade payables 5,162 7,400 9,036 10,894 12,769
Other current liabilities 3,253 3,923 4,791 5,776 6,770
Short term provisions 515 762 931 1,122 1,315
Total current liabilities 11,220 13,429 16,102 19,135 22,198
Total liabilities 36,240 41,134 42,329 45,236 48,803
Total equity and liabilities 93,800 103,195 129,371 137,581 148,731
Source: Ambit Capital research, Company
Preferred Ratios
Year to March (₹ mn) FY24 FY25 FY26E FY27E FY28E
Gross margin 67.3% 67.9% 68.8% 69.1% 69.4%
EBITDA margin 12.4% 14.7% 18.5% 19.8% 21.0%
EBIT margin 0.0% 2.7% 5.4% 5.6% 7.1%
Net profit margin (0.2%) 4.5% 4.3% 5.4% 6.6%
Interest cover - 1.2 2.7 3.8 5.9
Net debt/equity (0.2) (0.2) (0.3) (0.3) (0.3)
Source: Ambit Capital research, Company
Ratio analysis
Year to March (₹ mn) FY24 FY25 FY26E FY27E FY28E
Gross margin 67.3% 67.9% 68.8% 69.1% 69.4%
EBITDA margin 12.4% 14.7% 18.5% 19.8% 21.0%
EBIT margin 0.0% 2.7% 5.4% 5.6% 7.1%
Net profit margin (0.2%) 4.5% 4.3% 5.4% 6.6%
Interest cover - 1.2 2.7 3.8 5.9
Net debt/equity (0.2) (0.2) (0.3) (0.3) (0.3)
Net debt/EBITDA (1.9) (1.5) (1.8) (1.5) (1.4)
Working capital turnover 10.6 14.2 14.2 14.2 14.2
Cash conversion days 35 26 26 26 26
Inventory days 46 59 59 59 59
Receivable days 23 6.9 6.9 6.9 6.9
Payable days 35 41 41 41 41
Gross block turnover 1.1 1.0 0.9 0.9 0.9
pre-tax CFO/EBITDA 81.0% 137% 82.2% 86.0% 88.9%
pre-tax RoCE 0.0% 2.2% 4.4% 4.9% 6.9%
post-tax RoCE 0.0% 1.7% 3.4% 3.8% 5.4%
pre-tax RoIC 0.0% 2.8% 5.9% 6.8% 9.9%
post-tax RoIC 0.0% 2.2% 4.6% 5.3% 7.6%
ROE (%) (0.2%) 5.1% 4.7% 6.0% 8.0%
Source: Ambit Capital research, Company
Valuation parameters
Year to March (₹ mn) FY24 FY25 FY26E FY27E FY28E
PE (9.4) 0.6 0.5 0.3 0.2
Source: Ambit Capital research, Company
Explanation of Investment Rating - Our target prices are with a 12-month perspective. Returns stated are our internal benchmark
Investment Rating Expected return (over 12-month)
BUY We expect this stock to deliver more than 10% returns over the next12 month
SELL We expect this stock to deliver less than or equal to 10 % returns over the next 12 months
UNDER REVIEW We have coverage on the stock but we have suspended our estimates, TP and recommendation for the time being NOT
NOT RATED We do not have any forward-looking estimates, valuation, or recommendation for the stock.
Note: At certain times the Rating may not be in sync with the description above as the stock prices can be volatile and analysts can take time to react to development.
Disclaimer
This report or any portion hereof may not be reprinted, sold or redistributed without the written consent of Ambit Capital Private Ltd. Ambit Capital Private Ltd. research is disseminated and available primarily
electronically, and, in some cases, in printed form. The following Disclosures are being made in compliance with the SEBI (Research Analysts) Regulations, 2014 (herein after referred to as the Regulations) and
guidelines issued from time to time
Disclosures
▪ Ambit Capital Private Limited (“Ambit Capital or Ambit”) is a SEBI Registered Research Analyst having registration number INH000000313 and Research [Link] No. 5020. Ambit Capital, the
Research Entity (RE) as defined in the Regulations, is also engaged in the business of providing Stock broking Services, Depository Participant Services. Ambit Capital is a wholly owned subsidiary company
of Ambit Private Limited. The details of associate entities of Ambit Capital are available on its website.
▪ Ambit Capital makes its best endeavor to ensure that the research analyst(s) use current, reliable, comprehensive public information and obtain such information from sources which the analyst(s)
believes to be reliable. However, such information has not been independently verified by Ambit Capital and/or the analyst(s) and no representation or warranty, express or implied, is made as to the
accuracy or completeness of any information obtained from third parties. The information, opinions, views expressed in this Research Report are those of the research analyst as at the date of this
Research Report which are subject to change and do not represent to be an authority on the subject. Ambit Capital and its affiliates/ group entities may or may not subscribe to any and/ or all the views
expressed herein and the statements made herein by the research analyst may differ from or be contrary to views held by other businesses within the Ambit group.
▪ This Research Report should be read and relied upon at the sole discretion and risk of the recipient. If you are dissatisfied with the contents of this Research Report or with the terms of this Disclaimer,
your sole and exclusive remedy is to stop using this Research Report and Ambit Capital or its affiliates shall not be responsible and/ or liable for any direct/consequential loss howsoever directly or
indirectly, from any use of this Research Report.
▪ If this Research Report is received by any client of Ambit Capital or its affiliates, the relationship of Ambit Capital/its affiliate with such client will continue to be governed by the existing terms and
conditions in place between Ambit Capital/ such affiliates and the client.
▪ This Research Report is being supplied to you solely for your information and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or published, copied in whole
or in part, for any purpose. Neither this Research Report nor any copy of it may be taken or transmitted or distributed, directly or indirectly within India or into any other country including United States
(to US Persons), Canada or Japan or to any resident thereof. The distribution of this Research Report in other jurisdictions may be strictly restricted and/ or prohibited by law or contract, and persons into
whose possession this Research Report comes should aware of and take note of such restrictions.
▪ This research report may incorporate the use of Artificial Intelligence (AI) tools to assist in the information-gathering stage, including the compilation or collation of data from publicly available sources
or databases used by Ambit Capital. AI tools may also support content creation and other research-related processes. Ambit Capital remains fully responsible for the accuracy, integrity, and confidentiality
of all data used, as well as for the insights and recommendations provided. Any output generated with the assistance of AI tools is subject to review and professional judgment to ensure reliability and
compliance with applicable laws and standards.”
▪ Ambit Capital declares that neither its activities were suspended nor did it default with any stock exchange with whom it is registered since inception. Ambit Capital has not been debarred from doing
business by any Stock Exchange, SEBI, Depository or other Regulated Authorities, nor has the certificate of registration been cancelled by SEBI at any point in time.
▪ A part from the case of Manappuram Finance Ltd. where Ambit Capital settled the matter with SEBI without accepting or denying any guilt, there is no material disciplinary action that has been taken by
any regulatory authority impacting research activities of Ambit Capital.
▪ A graph of daily closing prices of securities is available at [Link] and [Link]
reliable and accurate. However, it has not been prepared in accordance with legal requirements designed to promote the independence of investment research. It has also not been independently
verified and no representation or warranty, express or implied, is made as to the accuracy or completeness of any information obtained from third parties.
▪ The information or opinions are provided as at the date of this report and are subject to change without notice. The information and opinions provided in this report take no account of the investors’
individual circumstances and should not be taken as specific advice on the merits of any investment decision. Investors should consider this report as only a single factor in making any investment
decisions. Further information is available upon request. No member or employee of Ambit accepts any liability whatsoever for any direct or consequential loss howsoever arising, directly or indirectly,
from any use of this report or its contents.
▪ The value of any investment made at your discretion based on this Report, or income therefrom, maybe affected by changes in economic, financial and/or political factors and may go down as well as
go up and you may not get back the original amount invested. Some securities and/or investments involve substantial risk and are not suitable for all investors.
▪ Ambit and its affiliates and their respective officers directors and employees may hold positions in any securities mentioned in this Report (or in any related investment) and may from time to time add
to or dispose of any such securities (or investment). Ambit and its affiliates may from time to time render advisory and other services, solicit business to companies referred to in this Report and may
receive compensation for the same. Ambit has a restrictive policy relating to personal dealing. Ambit has controls in place to manage the risks related to such. An outline of the general approach taken
in relation to conflicts of interest is available upon request.
▪ Ambit and its affiliates may act as a market maker or risk arbitrator or liquidity provider or may have assumed an underwriting commitment in the securities of companies discussed in this Report (or in
related investments) or may sell them or buy them from clients on a principal to principal basis or may be involved in proprietary trading and may also perform or seek to perform investment banking or
underwriting services for or relating to those companies.
▪ Ambit may sell or buy any securities or make any investment which may be contrary to or inconsistent with this Report and are not subject to any prohibition on dealing. By accepting this report you
agree to be bound by the foregoing limitations. In the normal course of Ambit and its affiliates’ business, circumstances may arise that could result in the interests of Ambit conflicting with the interests
of clients or one client’s interests conflicting with the interest of another client. Ambit makes best efforts to ensure that conflicts are identified, managed and clients’ interests are protected. However,
clients/potential clients of Ambit should be aware of these possible conflicts of interests and should make informed decisions in relation to Ambit services.
This publication may be furnished to recipients in the United States directly by Ambit Capital and in certain cases indirectly by Daiwa Capital Markets America Inc. (“DCMA”), a U.S. Securities and Exchange
Commission registered broker-dealer and FINRA member firm, exclusively to “major U.S. institutional investors”, as defined under Rule 15a-6 promulgated under the U.S. Securities Exchange Act of 1934, as
amended, and as interpreted by the staff of the U.S. Securities and Exchange Commission. U.S. customers to whom Ambit capital or DCMA have furnished this publication and that wish to effect transactions
in any designated investment discussed in this publication should do so through a qualified salesperson of DCMA. DCMA registered representative may be reached at 212-612-7000. DCMA does not take
responsibility for the contents of this publication. DCMA has not been involved in producing this publication. DCMA does not review this publication prior to its publication and has no influence on content and
rating. This publication is not an offer to sell or the solicitation of any offer to buy securities by available Ambit Capital or DCMA. For further disclosures from DCMA, please see the notice when it furnishes the
publication. This material should not be construed as a solicitation or recommendation to use Ambit Capital to effect transactions in any security mentioned herein, and is not supplied with any understanding
that US recipients will direct commission business to Ambit Capital. Analysts preparing this research report are employed outside of the US and are not registered as research analysts with FINRA. These analysts
may not be associated persons of DCMA and therefore may not be subject to FINRA Rule 2241 restrictions on communications with a subject company, public appearances and trading securities held by a
research analyst account.
Analyst(s) Certification
▪ The analyst(s) authoring this research report hereby certifies that the views expressed in this research report accurately reflect such research analyst's personal views about the subject securities and
issuers and that no part of his or her compensation was, is, or will be directly or indirectly related to the specific recommendations or views contained in the research report.
▪ The analyst (s) has/have not served as an officer, director or employee of the subject company in the last 12 months period ending on the last day of the month immediately preceding the date of
publication of this research report.
▪ The analyst(s) does not hold one percent or more securities of the subject company, at the end of the month immediately preceding the date of publication of the research report.
▪ Research Analyst views on Subject Company may vary based on fundamental research and technical research. Proprietary trading desk of Ambit Capital or its associates/group companies maintains
arm’s length distance with the research team as all the activities are segregated from Ambit Capital research activity and therefore it can have an independent views with regards to Subject Company
for which research team have expressed their views.